At a glance
- Originator Yamanouchi
- Class Antihyperglycaemics; Small molecules; Thiazolidinediones
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Type 2 diabetes mellitus
Most Recent Events
- 15 Jun 1999 Preclinical development for Type-2 diabetes mellitus in Japan (PO)